Surefire Medical is pleased to announce the appointment of Anil Singhal, PhD, to its board of directors.
Team
Clinical News
Clinical Data Shows Surefire Technology Provides 80% Complete Response Rate for Bridge-to-Transplant Primary Liver Cancer Treatment versus 52% for Standard Microcatheter
